Last reviewed · How we verify
Medical prescription after ovulation
Medical prescription after ovulation is a Small molecule drug developed by Peking University Third Hospital. It is currently in Phase 3 development for Luteal phase support in assisted reproductive technology (ART) cycles, Enhancement of endometrial receptivity and implantation rates.
A post-ovulation medical intervention designed to support luteal phase function and optimize conditions for embryo implantation.
A post-ovulation medical intervention designed to support luteal phase function and optimize conditions for embryo implantation. Used for Luteal phase support in assisted reproductive technology (ART) cycles, Enhancement of endometrial receptivity and implantation rates.
At a glance
| Generic name | Medical prescription after ovulation |
|---|---|
| Sponsor | Peking University Third Hospital |
| Modality | Small molecule |
| Therapeutic area | Reproductive Medicine / Fertility |
| Phase | Phase 3 |
Mechanism of action
This appears to be a luteal phase support therapy administered after ovulation to enhance progesterone signaling or endometrial receptivity. The exact molecular mechanism is not publicly detailed, but post-ovulation treatments typically work by supplementing or enhancing progesterone levels, improving endometrial thickness, or modulating immune tolerance during the implantation window.
Approved indications
- Luteal phase support in assisted reproductive technology (ART) cycles
- Enhancement of endometrial receptivity and implantation rates
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical prescription after ovulation CI brief — competitive landscape report
- Medical prescription after ovulation updates RSS · CI watch RSS
- Peking University Third Hospital portfolio CI
Frequently asked questions about Medical prescription after ovulation
What is Medical prescription after ovulation?
How does Medical prescription after ovulation work?
What is Medical prescription after ovulation used for?
Who makes Medical prescription after ovulation?
What development phase is Medical prescription after ovulation in?
Related
- Manufacturer: Peking University Third Hospital — full pipeline
- Therapeutic area: All drugs in Reproductive Medicine / Fertility
- Indication: Drugs for Luteal phase support in assisted reproductive technology (ART) cycles
- Indication: Drugs for Enhancement of endometrial receptivity and implantation rates
- Compare: Medical prescription after ovulation vs similar drugs
- Pricing: Medical prescription after ovulation cost, discount & access